Growing adoption of DIY (Do-it-Yourself) testing and diagnostics concept is expected to drive the growth of United States patient at home testing kits market.
According to TechSci report on, “United States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others), By Sample (Blood, Urine, Saliva), By Usage (Disposable v/s Reusable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast & Opportunities, 2026”, United States patient at home testing kits market stood at USD3239.54 million and is expected to grow at a CAGR of 7.94% during the forecast period. The growing healthcare awareness among the population about the prevalence, causes, symptoms, diagnosis, and treatment of different diseases is expected to fuel the growth of the United States patient at home testing kits market.
The population in the country has become quite conscious and aware about different diseases and a paradigm shift has been observed in the behavior of the general population towards preventive healthcare rather than curative healthcare. This will certainly increase the demand for at home testing kits in the coming years. Additionally, the growing prevalence of chronic diseases such as cardiovascular diseases and diabetes is expected to support the market growth through 2026. United States is home to the world’s third largest diabetic population. Around 30.3 million adults in the United States are suffering from diabetes which is almost 1 in 10 adults. Cardiovascular diseases are the leading cause of death in the United States, with around 659,041 reported deaths in 2019.
The major factors contributing to cardiovascular diseases in the United States are diabetes and high cholesterol. This in turn is expected to increase the demand for blood glucose testing and cholesterol testing segment of patient at home testing kits market. However, it has been observed that although the patient at home testing kits is convenient, easy to use and deliver rapid results but sometimes the results of these tests are not correct, i.e., the diagnosis done by these testing kits is not correct. This is very commonly observed in case of pregnancy/fertility testing kits wherein false positive or false negative results are generated. This in turn leads to reliability constraints among the users and they prefer going to the doctor at early stages only rather than taking self-tests at home.
Browse over 25 market data Figures and 2 data Tables spread through 84 Pages and an in-depth TOC on "United States Patient At Home Testing Kits Market"
United States patient at home testing kits market can be segmented into test type, sample, usage, distribution channel, region and company. Based on sample, the United States patient at home testing kits market can be categorized into blood, urine and saliva. The blood sample segment dominated the market in 2020 with a share of around 44.50% and will continue to maintain its dominance in the forecast period as well since blood samples are used to perform majority of patient at home diagnostic tests including blood glucose monitoring, HIV testing, prothrombin test, among others. However, the share for saliva significantly increased in 2021 on account of their widespread use in at home COVID-19 testing.
While the urine samples are majorly used in pregnancy/fertility testing and urine analysis. By usage, the United States patient at home testing kits market can be segmented into disposable kits and reusable kits. Disposable kits hold a larger share in the patient at home testing kit market and will continue to grow in the forecast period. The reason for the uninterrupted demand for disposable kit will directly depend on their consumer behavior. Most of the self- diagnostic tests, which primarily include sources like saliva, urine testing which require disposable kits. Moreover, increasing awareness regarding health and hygiene after COVID-19 outbreak is one of the leading factors to use disposable kits, only to prevent the further spread of infection. Diagnostic tests done by reusable kits are disease specific and require more attention while handling as compared to disposable kits.
Major players operating in the United States patient at home testing kits market include Lucira Health Inc., Essenlix Corporation, Abbott Laboratories, Inc., Roche Diagnostics Corporation, Siemens Medical Solutions USA, Inc., Thermo Fischer Scientific, Inc., Scanwell Health, Inc., Quidel Corporation, GE Healthcare, Inc., ACON Laboratories, Inc., among others.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7556
Customers can also request for 10% free customization on this report.
“The growing adoption of telemedicine and remote patient monitoring in the United States has significantly increased the demand for patient at home testing kits. Additional advancements such as use of digital pregnancy kits, pregnancy strip self-test, among others are further expected to support the market growth through 2026.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Patient At Home Testing Kits Market By Test Type (Blood Glucose Testing, Pregnancy & Fertility Testing, Cholesterol Testing, Urine Testing, COVID-19 Testing, Others), By Sample (Blood, Urine, Saliva), By Usage (Disposable v/s Reusable), By Distribution Channel (Retail Pharmacy Stores, Hypermarket/Supermarket, E-Commerce) By Region, Competition Forecast & Opportunities, 2026” has evaluated the future growth potential of United States patient at home testing kits market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States patient at home testing kits market.
Browse Related Projects:
Global Allergy Diagnostics Market By Product (Assay Kits, Instruments, Consumables, Services) By Allergy Type (Food, Seasonal, Drug, Inhalant, Anaphylaxis/Contact Allergies, Others) By Test (In Vivo, In Vitro) By End User (Hospital, Diagnostic Laboratory, Academic and Research Institutes, Others) By Company, By Region, Forecast & Opportunities, 2026
Global Coronavirus Testing Kits Market By Type of Test (Molecular v/s Serological), By Use (Multiple Test v/s Single Test), By Full Test Time (5 Hours-12Hours, 1 Hours-5 Hours, 15-60 Minutes, Less than 15 Minutes, 12 Hours-24Hours, More Than 1 Day), By Technology (RT-PCR, Rapid Diagnostic Test, ELISA Tests, Others), By Specimen Type (Nasopharyngeal specimen, Oropharyngeal specimen, Blood, Sputum, Others), By Mobility (Stationary v/s Mobile), By End Use (Public Health Labs, Hospitals, Private or Commercial Labs, Physician Labs, Others), By Region, Competition Forecast & Opportunities, 2026
Mr. Ken Mathews
708 Third Avenue,
New York – 10017
For More Market Research Blogs Visit: https://techsciblog.com/